🇺🇸 FDA
Pipeline program

LUCAR-E9D or LUCAR-E9K cells product

LB2406-0001

Phase 1 mab active

Quick answer

LUCAR-E9D or LUCAR-E9K cells product for B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory
Phase
Phase 1
Modality
mab
Status
active

Clinical trials